A biotech company in the San Francisco Bay area is working on a pill, fostamatinib, to fight the auto-immune inflammatory process that destroys our kidneys in IgAN. They are in Stage 3 clinical trials on the very closely related purpurea condition and in stage 2 clinical trials on IgAN for this new drug. It looks promising.
The video provides a good description of the disease process in IgAN.
To read what Rigel has to say about IgAN here’s read more here.